City Therapeutics is a biopharmaceutical company harnessing next-generation engineering of RNAi trigger molecules to improve and expand the reach of RNAi-based medicines. The comp…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
City Therapeutics is a biopharmaceutical company harnessing next-generation engineering of RNAi trigger molecules to improve and expand the reach of RNAi-based medicines. The comp…
Imbria Pharmaceuticals is a clinical-stage company transforming the treatment of cardiovascular disease by targeting cardiac energy metabolism. The company’s focus is ninerafaxsta…
PAhR Therapeutics is a clinical-stage company focused on developing novel mechanisms for the treatment of pulmonary arterial hypertension (PAH).
Capacity Bio is a private, Los Angeles-based biotech company developing a first-in-class mitophagy therapeutic platform, along with the most advanced analytical toolkit to charact…
Pillar Therapeutics specializes in next-generation sequencing (NGS) technologies for precision medicine, focusing on NGS solutions to support personalized therapy.
Typewriter Therapeutics is a biotech company developing safe, durable, and re-dosable genetic medicines with curative impact for patients with cancer, autoimmune diseases, and sev…
Crystalys Therapeutics is a biotechnology company specializing in the development and commercialization of therapeutic products, focusing on treatments for serious respiratory dis…
Tortugas Neuroscience is focused on developing novel medicines targeting complex brain disorders with large, well-defined patient populations. The company’s strategy centers on le…